At a glance

ClinicalIndex Comparison Record

N/ACompleted· 525 enrolled

Drug / intervention

office setting +1 moreother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02395536

NCT02395536N/ACompleted

Compare CT.gov

Reveal LINQ™ In-Office 2 (RIO 2) Study United States

Medtronic Cardiac Rhythm and Heart Failure·interventional·Posted Mar 23, 2015·Updated Oct 4, 2017

In Brief

A clinical study evaluating office setting and hosptial setting for Arrhythmia. Completed, enrolled 525 participants across 27 sites.

Detailed Summary

The primary purpose of the RIO 2 study is to demonstrate that when the Reveal LINQ™ insertable cardiac monitoring (ICM) system that records subcutaneous ECG insertion procedure performed in the in-office setting is as safe as LINQ™ insertions performed in the traditional hospital setting (operating room, cardiac catheterization or electrophysiology (EP) laboratory).

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsArrhythmia

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

201520162017201820192020202120222023202420252026

First PostedMar 2015

Enrollment StartMar 2015

Primary CompletionMay 2016

TodayJul 2026

First PostedMar 23, 2015

Enrollment StartMar 30, 2015

Primary CompletionMay 31, 2016

TodayJul 2, 2026

Enrollment to primary: 1.2 yearsPosted 11.3 years ago

Interventions

office settingother

An office setting was defined as a procedure or office room with controlled entry and hard floors outside the walls of the hospital and not including ambulatory surgical centers

hosptial settingother

A hospital setting was defined as an operating room or electrophysiology lab inside the walls of a hospital.